Watkins, P. B., Lewis, J. H., Kaplowitz, N., Alpers, D. H., Blais, J. D., Smotzer, D. M., . . . Zimmer, C. A. (2015). Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database. Drug safety, 38(11), 1103-1113. https://doi.org/10.1007/s40264-015-0327-3
Chicago-Zitierstil (17. Ausg.)Watkins, Paul B., et al. "Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database." Drug Safety 38, no. 11 (2015): 1103-1113. https://doi.org/10.1007/s40264-015-0327-3.
MLA-Zitierstil (9. Ausg.)Watkins, Paul B., et al. "Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database." Drug Safety, vol. 38, no. 11, 2015, pp. 1103-1113, https://doi.org/10.1007/s40264-015-0327-3.